Evaluation of plasma, salivary, and urinary cortisol levels for diagnosis of Cushing's syndrome. 2010

Satoru Sakihara, and Kazunori Kageyama, and Yutaka Oki, and Masaru Doi, and Yasumasa Iwasaki, and Shinobu Takayasu, and Takako Moriyama, and Ken Terui, and Takeshi Nigawara, and Yukio Hirata, and Kozo Hashimoto, and Toshihiro Suda
Department of Endocrinology and Metabolism, Hirosaki University Graduate School of Medicine, Aomori, Japan.

As a screening test for Cushing's syndrome, the evaluation of late-night cortisol levels is indispensable. We evaluated the usefulness and accuracy of plasma, urinary, and salivary cortisol levels measured late at night for the diagnosis of Cushing's syndrome. High cortisol levels (> 5 microg/dL) during the night are indicative of Cushing's syndrome, although night plasma cortisol levels are not readily reproducible because of the stressful situation. There was no correlation between plasma and urinary cortisol levels late at night, and late-night urinary cortisol levels provided weak information for the diagnosis of Cushing's syndrome. By contrast, late-night plasma and salivary cortisol levels showed a positive correlation, and salivary cortisol sampling was found to be useful for the diagnosis of Cushing's syndrome, because more than 0.4 microg/dL of late-night salivary cortisol levels gave a sensitivity of 86% and a specificity of 100% in our hospital. This method is also useful for the diagnosis of early or mild stage Cushing's syndrome, so-called subclinical Cushing's syndrome. Inherent differences between assays make it difficult to define optimal diagnostic criteria. However, the relative levels of salivary cortisol ratio, which is presented as a relative level, compared with the mean levels of healthy subjects in each institute, is useful for the screening of Cushing's syndrome as the cut-off level of 1.5 shows both high sensitivity and specificity in subclinical and overt Cushing's syndrome. Late-night salivary cortisol measurement is therefore a primary method of choice in the screening of patients suspected of having Cushing's syndrome.

UI MeSH Term Description Entries
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D003480 Cushing Syndrome A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent. Cushing's Syndrome,Hypercortisolism,Syndrome, Cushing,Syndrome, Cushing's
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D012463 Saliva The clear, viscous fluid secreted by the SALIVARY GLANDS and mucous glands of the mouth. It contains MUCINS, water, organic salts, and ptylin. Salivas
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face

Related Publications

Satoru Sakihara, and Kazunori Kageyama, and Yutaka Oki, and Masaru Doi, and Yasumasa Iwasaki, and Shinobu Takayasu, and Takako Moriyama, and Ken Terui, and Takeshi Nigawara, and Yukio Hirata, and Kozo Hashimoto, and Toshihiro Suda
September 1985, Clinica chimica acta; international journal of clinical chemistry,
Satoru Sakihara, and Kazunori Kageyama, and Yutaka Oki, and Masaru Doi, and Yasumasa Iwasaki, and Shinobu Takayasu, and Takako Moriyama, and Ken Terui, and Takeshi Nigawara, and Yukio Hirata, and Kozo Hashimoto, and Toshihiro Suda
January 2012, Endocrine journal,
Satoru Sakihara, and Kazunori Kageyama, and Yutaka Oki, and Masaru Doi, and Yasumasa Iwasaki, and Shinobu Takayasu, and Takako Moriyama, and Ken Terui, and Takeshi Nigawara, and Yukio Hirata, and Kozo Hashimoto, and Toshihiro Suda
March 2012, Pituitary,
Satoru Sakihara, and Kazunori Kageyama, and Yutaka Oki, and Masaru Doi, and Yasumasa Iwasaki, and Shinobu Takayasu, and Takako Moriyama, and Ken Terui, and Takeshi Nigawara, and Yukio Hirata, and Kozo Hashimoto, and Toshihiro Suda
September 2003, The Journal of clinical endocrinology and metabolism,
Satoru Sakihara, and Kazunori Kageyama, and Yutaka Oki, and Masaru Doi, and Yasumasa Iwasaki, and Shinobu Takayasu, and Takako Moriyama, and Ken Terui, and Takeshi Nigawara, and Yukio Hirata, and Kozo Hashimoto, and Toshihiro Suda
June 2014, The Journal of clinical endocrinology and metabolism,
Satoru Sakihara, and Kazunori Kageyama, and Yutaka Oki, and Masaru Doi, and Yasumasa Iwasaki, and Shinobu Takayasu, and Takako Moriyama, and Ken Terui, and Takeshi Nigawara, and Yukio Hirata, and Kozo Hashimoto, and Toshihiro Suda
December 1984, Casopis lekaru ceskych,
Satoru Sakihara, and Kazunori Kageyama, and Yutaka Oki, and Masaru Doi, and Yasumasa Iwasaki, and Shinobu Takayasu, and Takako Moriyama, and Ken Terui, and Takeshi Nigawara, and Yukio Hirata, and Kozo Hashimoto, and Toshihiro Suda
April 2005, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association,
Satoru Sakihara, and Kazunori Kageyama, and Yutaka Oki, and Masaru Doi, and Yasumasa Iwasaki, and Shinobu Takayasu, and Takako Moriyama, and Ken Terui, and Takeshi Nigawara, and Yukio Hirata, and Kozo Hashimoto, and Toshihiro Suda
October 2002, The Journal of clinical endocrinology and metabolism,
Satoru Sakihara, and Kazunori Kageyama, and Yutaka Oki, and Masaru Doi, and Yasumasa Iwasaki, and Shinobu Takayasu, and Takako Moriyama, and Ken Terui, and Takeshi Nigawara, and Yukio Hirata, and Kozo Hashimoto, and Toshihiro Suda
June 2012, Endocrine,
Satoru Sakihara, and Kazunori Kageyama, and Yutaka Oki, and Masaru Doi, and Yasumasa Iwasaki, and Shinobu Takayasu, and Takako Moriyama, and Ken Terui, and Takeshi Nigawara, and Yukio Hirata, and Kozo Hashimoto, and Toshihiro Suda
June 2008, Nature clinical practice. Endocrinology & metabolism,
Copied contents to your clipboard!